DMPA-SC Self-Injection Best Practices Project Brief

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s Self-Injection Best Practices project, which aims to evaluate and identify optimal program models for DMPA-SC self-injection. For more information, sign up for our newsletter, or email FPoptions@path.org.

Corporate author(s): PATH

Publication date: November 2018

Available materials

  1. English

    1. DMPA-SC Self-Injection Best Practices Project: Uganda 238.5 KB PDF

      Hard copies are not available.

  2. French

    1. Self-Injection Best Practices Project: Uganda [French] 341.7 KB PDF

      Hard copies are not available.